Highdose Ara-C/Idarubicin induction and high dose Etoposide/Cytoxan intensification in AML.

被引：0
|
作者：
Kurian, S [1 ]
Qazilbash, MH [1 ]
Lynch, JP [1 ]
Beall, CL [1 ]
Weisenborn, R [1 ]
Bunner, P [1 ]
Hobbs, G [1 ]
Auber, M [1 ]
Ericson, SG [1 ]
机构：
[1] W Virginia Univ, Bone Marrow Transplant Program, Morgantown, WV USA
来源：
BLOOD | 2000年 / 96卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
4641
引用
收藏
页码：213B / 213B
页数：1
相关论文
共 50 条
  • [41] HIGH-DOSE ARA-C THERAPY - A REVIEW
    GASSMANN, W
    SCHMITZ, N
    LOFFLER, H
    ONKOLOGIE, 1985, 8 (01): : 8 - &
  • [42] Autophagy induction of Acute Myeloid Leukemia (AML) cells after treatment with low dose-cytarabine (Ara-C) and enhanced cytocidal effect on AML cells by combined treatment with ara-c plus lenograstim
    Tang, Yongmin
    Li, Lixia
    Wang, Di
    Shen, Hongqiang
    Qian, Baiqin
    Luo, Chunfang
    Zhang, Haizhong
    BLOOD, 2007, 110 (11) : 114B - 114B
  • [43] CONTINUOUS LOW-DOSE INFUSIONS OF ARA-C IN MANAGEMENT OF PATIENTS WITH AML
    POTTER, CG
    BUNCH, C
    PIPPARD, MJ
    ROWELL, AC
    BRITISH JOURNAL OF CANCER, 1978, 38 (01) : 181 - 181
  • [44] INTERMEDIATE DOSE ARA-C AND AMSA FOR TREATMENT OF RELAPSED AND REFRACTORY ADULT AML
    JEHN, U
    KOLB, HJ
    WILMANNS, W
    BLUT, 1988, 57 (04): : 190 - 190
  • [45] Intermittent intermediate dose ARA-C as consolidation therapy for AML in the elderly.
    Sperr, WR
    Piribauer, M
    Agis, H
    Mitterbauer, M
    Geissler, K
    Haas, O
    Fonatsch, C
    Jager, U
    Schwarzinger, I
    Thalhammer, F
    Valent, P
    Lechner, K
    BLOOD, 1997, 90 (10) : 2267 - 2267
  • [46] Low Dose Ara-C Versus Low Dose Ara-C and Arsenic Trioxide: the UK NCRI AML16 "Pick a Winner" Comparison.
    Russell, Nigel H.
    Hills, Robert K.
    Hunter, Ann E.
    Milligan, Donald
    Kell, William J.
    Wheatley, Keith
    McMullin, Mary Frances
    Yin, John A. L.
    Bowen, David T.
    Burnett, A.
    BLOOD, 2009, 114 (22) : 201 - 201
  • [47] LOW-DOSE ARA-C AS AN ALTERNATIVE THERAPY FOR OLDER PATIENTS WITH AML
    HEYLL, A
    AUL, C
    HEYLL, U
    FISCHER, JT
    SCHNEIDER, W
    BLUT, 1985, 51 (03): : 163 - 163
  • [48] Ara-C fever and infections after high-dose Ara-C treatment in pediatric lymphoid malignancies
    Ek, T
    Pinkava, M
    Abrahamsson, J
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2005, 27 (07) : 364 - 369
  • [49] SATURATION OF ARA-CTP ACCUMULATION DURING HIGH-DOSE ARA-C THERAPY - PHARMACOLOGICAL RATIONALE FOR INTERMEDIATE-DOSE ARA-C
    PLUNKETT, W
    LILIEMARK, JO
    ESTEY, E
    KEATING, MJ
    SEMINARS IN ONCOLOGY, 1987, 14 (02) : 159 - 166
  • [50] MODULATION OF CYTOSINE-ARABINOSIDE (ARA-C) AND HIGH-DOSE ARA-C IN ACUTE-LEUKEMIA
    ZITTOUN, R
    MARIE, JP
    ZITTOUN, J
    MARQUET, J
    HAANEN, C
    SEMINARS IN ONCOLOGY, 1985, 12 (02) : 139 - 143
12345